all I've seen regarding that is a post mentioning info from the CC (I won't be able to listen until tonight)..definitely positive though.
1) Raises FY10 guidance on top and bottom 2) Expects ECR to significantly increase Hi-Tech's footprint across all markets. 3) See's major shift to generics as current administration continues on health care reform, providing Hi-Tech with a huge opportunity for growth.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.